Brief: Carisma Therapeutics Announces Restructuring
09/12/2024 13:35
Dec 9 (Reuters) - Carisma Therapeutics CARM.O :
* CARISMA THERAPEUTICS ANNOUNCES STRATEGIC RESTRUCTURING TO
RE-PRIORITIZE PIPELINE
* CARISMA THERAPEUTICS INC -DEVELOPMENT OF CT-0525 TO BE
DISCONTINUED; WORKFORCE REDUCED BY 34%
* CARISMA THERAPEUTICS INC - EXPECTS $2.7 MILLION COST FOR
WORKFORCE REDUCTION
* CARISMA THERAPEUTICS INC - CHIEF FINANCIAL OFFICER,
RICHARD
MORRIS WILL LEAVE COMPANY EFFECTIVE DEC 31
Source text: ID:nPnbC3VgDa
Further company coverage: CARM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Carisma Therapeutics
See all newsBrief: Carisma Therapeutics & Modernatx Amend Collaboration & And License Agreement - SEC Filing
Carisma Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Carisma Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview
Brief: Carisma Therapeutics And Orthocellix Enter Into Definitive Merger Agreement
Carisma Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary